Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Quanex Building Products
Quanex Building Products Announces First Quarter 2026 Results and Provides Full Year 2026 Guidance
Business
Mar 5 2026
22 min read

Quanex Building Products Announces First Quarter 2026 Results and Provides Full Year 2026 Guidance

news images

Net Sales Growth of ~2% Year-Over-Year
Healthy Balance Sheet and Strong Liquidity
Well Positioned to Capitalize on Pent-Up Demand

HOUSTON, March 05, 2026 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended January 31, 2026.

The Company reported the following selected financial results:

 

Three Months Ended January 31,

($ in millions, except per share data)

2026

 

2025

Net Sales

$409.1

 

$400.0

Gross Margin

$98.5

 

$92.3

Gross Margin %

24.1%

 

23.1%

Net Loss

($4.1)

 

($14.9)

Diluted EPS

($0.09)

 

($0.32)

 

 

 

 

Adjusted Net (Loss) Income

($0.3)

 

$9.0

Adjusted Diluted EPS

($0.01)

 

$0.19

Adjusted EBITDA

$27.4

 

$38.5

Adjusted EBITDA Margin %

6.7%

 

9.6%

 

 

 

 

Cash Used For Operating Activities

($20.2)

 

($12.5)

Free Cash Flow

($31.5)

 

($24.1)

 

 

 

 

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, stated, “Our results for the first quarter tracked our expectations given the current macroeconomic backdrop. The combination of inflationary pressures, high interest rates, tariff uncertainty, housing affordability issues, and geopolitical tensions continued to weaken consumer confidence around the world, ultimately impacting demand for the products we manufacture. However, we continue to focus on identifying operational efficiencies and commercial synergies that we believe will benefit us when consumer confidence improves and demand rebounds.

“Due to the seasonality of our business, coupled with the longer cash conversion cycle of the legacy Tyman business, we expect to be a net borrower during the first half of our fiscal year, which impacts our leverage ratio. Our balance sheet is healthy, and we will remain focused on prioritizing debt repayment as we generate cash.   Looking ahead, we continue to be optimistic about our prospects for profitable growth and value creation.”

First Quarter 2026 Results Summary

Quanex reported net sales of $409.1 million during the three months ended January 1, 2026, which represents an increase of 2.3% compared to $400.0 million for the same period in 2025, mainly due to foreign exchange translation and the pass-through of tariffs. In its Hardware Solutions segment, Quanex reported an increase of 2.4% in net sales for the first quarter of 2026, mostly due to foreign exchange translation and price increases. In its Extruded Solutions segment, net sales were essentially flat for the first quarter of 2026 as lower volumes were offset by foreign exchange translation and price increases. For its Custom Solutions segment, the Company reported an increase of 4.8% in net sales for the first quarter of 2026, largely due to increased volume and improved pricing. (See Sales Analysis table for additional information)

On a consolidated basis, the decrease in adjusted earnings for the first quarter of 2026 compared to the first quarter of 2025 was mainly due to reduced operating leverage from lower volumes related to ongoing macroeconomic uncertainty coupled with low consumer confidence and higher, but temporary, operational costs related to Quanex’s window and door hardware plant in Monterrey, Mexico.

Balance Sheet & Liquidity Update

As of January 31, 2026, the Company had total debt of $717.5 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA was 2.8x. As of January 31, 2026, Quanex reported a LTM Net Loss of $240.0 million, mainly due to the non-cash goodwill impairment charge recorded in the third quarter of 2025, and LTM Adjusted EBITDA of $231.7 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The Company’s liquidity was $331.6 million as of January 31, 2026, consisting of $62.3 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Outlook

Mr. Wilson commented, “Our long-term view continues to be favorable as the underlying fundamentals for the residential housing market remain positive. We entered fiscal 2026 with a cautious outlook due to the ongoing macroeconomic challenges, but we continue to believe that demand for our products will improve as we expect consumer confidence to be restored over time. Based on conversations with our customers, recent demand trends, and the latest macro data, we are providing guidance for fiscal 2026. Overall, on a consolidated basis, we estimate we will generate net sales of $1.84 billion to $1.87 billion, which we expect will yield approximately $240 million to $245 million in Adjusted EBITDA* in fiscal 2026. As mentioned on our last earnings call, we anticipate the first half of 2026 to be more challenging than the first half of 2025, which implies an improved second half year-over-year.   As macroeconomic uncertainty subsides and consumer confidence improves, we believe we are well positioned to capitalize on pent-up demand.   In the meantime, we will stay focused on the things that we can control, with an emphasis on generating cash to pay down debt and opportunistically repurchasing our stock.”

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes related to net income. As a result, Quanex is unable to provide forward-looking net income guidance. Investors are cautioned that the Company’s Adjusted EBITDA excludes significant items, including interest expense, income taxes, depreciation and amortization, and the other adjustments described below, and that net income may differ materially from Adjusted EBITDA.

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, March 6, 2026, at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link:
https://register-conf.media-server.com/register/BIc6562606fc8b4f93a903be54b98e9c71

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets.  Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, asset impairment charges, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making.  Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making.   Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities.  The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.   Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: the Company’s ability to resolve an isolated operational issue at its window and door hardware plant located in Monterrey, Mexico, timing estimates or any other expectations related to the acquisition of Tyman, the impact of tariffs, trade restrictions and changes in trade policy on the Company’s raw material costs and supply chain, the impact of elevated interest rates on consumer demand for the Company’s products, Quanex’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to the Company’s industry, and Quanex’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. Therefore, you should not rely on any of these forward-looking statements. For a complete discussion of factors that may affect the Company’s future performance, please refer to Quanex’s Annual Report on Form 10-K for the fiscal year ended October 31, 2025, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements, whether written or oral, to reflect new information, developments or events.

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

Three Months Ended January 31,

 

2026

 

2025

 

 

 

 

Net sales

$

409,089

 

 

$

400,044

 

Cost of sales

 

310,562

 

 

 

307,728

 

Selling, general and administrative

 

71,426

 

 

 

66,650

 

Restructuring charges

 

-

 

 

 

7,904

 

Depreciation and amortization

 

24,249

 

 

 

24,740

 

Operating income (loss)

 

2,852

 

 

 

(6,978

)

Interest expense

 

(12,367

)

 

 

(14,186

)

Other, net

 

5,617

 

 

 

1,229

 

Loss before income taxes

 

(3,898

)

 

 

(19,935

)

Income tax (expense) benefit

 

(173

)

 

 

5,050

 

Net loss

$

(4,071

)

 

$

(14,885

)

 

 

 

 

Loss per common share, basic

$

(0.09

)

 

$

(0.32

)

Loss per common share, diluted

$

(0.09

)

 

$

(0.32

)

 

 

 

 

Weighted average common shares outstanding:

 

 

 

Basic

 

45,456

 

 

 

47,015

 

Diluted

 

45,456

 

 

 

47,015

 

 

 

 

 

Cash dividends per share

$

0.08

 

 

$

0.08

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)

 

 

 

 

 

January 31, 2026

 

October 31, 2025

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

62,311

 

 

$

76,018

 

Restricted Cash

 

2,332

 

 

 

2,100

 

Accounts receivable, net

 

189,243

 

 

 

205,384

 

Inventories

 

270,597

 

 

 

254,122

 

Prepaid assets

 

39,845

 

 

 

32,387

 

Other current assets

 

4,345

 

 

 

3,764

 

Total current assets

 

568,673

 

 

 

573,775

 

Property, plant and equipment, net

 

401,701

 

 

 

411,591

 

Operating lease right-of-use assets

 

179,221

 

 

 

154,866

 

Deferred tax assets

 

2,959

 

 

 

2,706

 

Goodwill

 

275,468

 

 

 

271,346

 

Intangible assets, net

 

544,323

 

 

 

549,137

 

Other assets

 

5,818

 

 

 

4,812

 

Total assets

$

1,978,163

 

 

$

1,968,233

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

116,095

 

 

$

131,307

 

Accrued liabilities

 

77,325

 

 

 

95,155

 

Income taxes payable

 

7,101

 

 

 

12,076

 

Current maturities of long-term debt

 

28,566

 

 

 

27,561

 

Current operating lease liabilities

 

16,749

 

 

 

15,446

 

Total current liabilities

 

245,836

 

 

 

281,545

 

Long-term debt

 

678,636

 

 

 

665,268

 

Noncurrent operating lease liabilities

 

168,668

 

 

 

145,459

 

Deferred income taxes

 

139,804

 

 

 

135,993

 

Other liabilities

 

14,865

 

 

 

13,789

 

Total liabilities

 

1,247,809

 

 

 

1,242,054

 

Stockholders’ equity:

 

 

 

Common stock

 

512

 

 

 

512

 

Additional paid-in-capital

 

695,426

 

 

 

700,029

 

Retained earnings

 

156,963

 

 

 

164,710

 

Accumulated other comprehensive loss

 

(24,329

)

 

 

(35,439

)

Treasury stock at cost

 

(98,218

)

 

 

(103,633

)

Total stockholders’ equity

 

730,354

 

 

 

726,179

 

Total liabilities and stockholders' equity

$

1,978,163

 

 

$

1,968,233

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)

 

 

 

 

 

Three Months Ended January 31,

 

2026

 

2025

Operating activities:

 

 

 

Net loss

$

(4,071

)

 

$

(14,885

)

Adjustments to reconcile net loss to cash used for operating activities:

 

 

 

Depreciation and amortization

 

24,249

 

 

 

24,740

 

Stock-based compensation

 

1,166

 

 

 

902

 

Deferred income tax

 

1,808

 

 

 

2,851

 

Other, net

 

1,300

 

 

 

6,173

 

Changes in assets and liabilities:

 

 

 

Decrease in accounts receivable

 

18,743

 

 

 

30,330

 

Increase in inventory

 

(13,669

)

 

 

(8,602

)

Increase in other current assets

 

(7,043

)

 

 

(8,985

)

Decrease in accounts payable

 

(13,982

)

 

 

(16,548

)

Decrease in accrued liabilities

 

(19,022

)

 

 

(22,558

)

Decrease in current income taxes payable

 

(5,203

)

 

 

(5,087

)

Other, net

 

(4,484

)

 

 

(841

)

Cash used for operating activities

 

(20,208

)

 

 

(12,510

)

Investing activities:

 

 

 

Capital expenditures

 

(11,294

)

 

 

(11,624

)

Proceeds from disposition of capital assets

 

55

 

 

 

169

 

Cash used for investing activities

 

(11,239

)

 

 

(11,455

)

Financing activities:

 

 

 

Borrowings under credit facilities

 

57,000

 

 

 

45,000

 

Repayments of credit facility borrowings

 

(36,250

)

 

 

(56,250

)

Repayments of other long-term debt

 

(838

)

 

 

(2,026

)

Common stock dividends paid

 

(3,638

)

 

 

(3,812

)

Issuance of common stock

 

-

 

 

 

214

 

Payroll tax paid to settle shares forfeited upon vesting of stock

 

(354

)

 

 

(1,400

)

Purchase of treasury stock

 

-

 

 

 

(3,698

)

Cash provided by (used for) financing activities

 

15,920

 

 

 

(21,972

)

Effect of exchange rate changes on cash and cash equivalents

 

2,052

 

 

 

(1,590

)

Decrease in cash, cash equivalents and restricted cash

 

(13,475

)

 

 

(47,527

)

Cash, cash equivalents and restricted cash at beginning of period

 

78,118

 

 

 

102,995

 

Cash, cash equivalents and restricted cash at end of period

$

64,643

 

 

$

55,468

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)

 

The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.

 

 

 

 

 

Three Months Ended January 31,

 

2026

 

2025

Cash used for operating activities

 

(20,208

)

 

 

(12,510

)

Capital expenditures

 

(11,294

)

 

 

(11,624

)

Free Cash Flow

 

(31,502

)

 

 

(24,134

)

 

 

 

 

 

 

 

 

The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.

 

 

 

 

 

As of January 31,

 

2026

 

2025

Term loan facility

$

462,500

 

 

$

487,500

 

Revolving credit facility

 

199,500

 

 

 

217,500

 

Finance lease obligations (1)

 

55,505

 

 

 

59,306

 

Total debt (2)

 

717,505

 

 

 

764,306

 

Less: Cash and cash equivalents

 

62,311

 

 

 

49,982

 

Net Debt

 

655,194

 

 

 

714,324

 

 

 

 

 

(1) Includes $49.3 million and $55.1 million in real estate lease liabilities considered finance leases under U.S. GAAP as of January 31, 2026 and 2025, respectively.

(2) Excludes outstanding letters of credit.

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Last Twelve Months Adjusted EBITDA

 

Three Months Ended
January 31, 2026

 

Three Months Ended
October 31, 2025

 

Three Months Ended
July 31, 2025

 

Three Months Ended
April 30, 2025

 

Total

 

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

Net (loss) income as reported

 

$

(4,071

)

 

$

19,571

 

 

$

(276,007

)

 

$

20,515

 

$

(239,992

)

Income tax (benefit) expense

 

 

173

 

 

 

15,147

 

 

 

(8,191

)

 

 

6,307

 

 

13,436

 

Other, net

 

 

(5,617

)

 

 

(5,246

)

 

 

(855

)

 

 

159

 

 

(11,559

)

Interest expense

 

 

12,367

 

 

 

13,468

 

 

 

14,218

 

 

 

13,940

 

 

53,993

 

Depreciation and amortization

 

 

24,249

 

 

 

25,630

 

 

 

33,882

 

 

 

19,192

 

 

102,953

 

Asset impairment charges

 

 

-

 

 

 

-

 

 

 

302,284

 

 

 

-

 

 

302,284

 

EBITDA

 

 

27,101

 

 

 

68,570

 

 

 

65,331

 

 

 

60,113

 

 

221,115

 

Cost of sales (1)

 

 

407

 

 

 

308

 

 

 

148

 

 

 

976

 

 

1,839

 

Selling, general and administrative (1),(2)

 

 

(126

)

 

 

2,056

 

 

 

3,449

 

 

 

1,110

 

 

6,489

 

Restructuring (credit) charges (3)

 

 

-

 

 

 

(16

)

 

 

1,367

 

 

 

936

 

 

2,287

 

Adjusted EBITDA

 

$

27,382

 

 

$

70,918

 

 

$

70,295

 

 

$

63,135

 

$

231,730

 

 

 

 

 

 

 

 

 

 

 

 

(1) Expense related to plant closure/relocation.

(2) Transaction, advisory fees, reorganization costs and product recall expenses.

(3) Restructuring (credit) charges related to severance.

 

 

 

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted Net Income and Adjusted EPS

 

Three Months Ended
January 31, 2026

 

Three Months Ended
January 31, 2025

 

 

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net loss as reported

 

$

(4,071

)

 

$

(0.09

)

 

$

(14,885

)

 

$

(0.32

)

 

Net loss reconciling items from below

 

 

3,801

 

 

$

0.08

 

 

 

23,847

 

 

$

0.51

 

 

Adjusted net income and adjusted EPS

 

$

(270

)

 

$

(0.01

)

 

$

8,962

 

 

$

0.19

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted EBITDA

 

Three Months Ended
January 31, 2026

 

Three Months Ended
January 31, 2025

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Net loss as reported

 

$

(4,071

)

 

 

 

$

(14,885

)

 

 

 

Income tax benefit

 

 

173

 

 

 

 

 

(5,050

)

 

 

 

Other, net

 

 

(5,617

)

 

 

 

 

(1,229

)

 

 

 

Interest expense

 

 

12,367

 

 

 

 

 

14,186

 

 

 

 

Depreciation and amortization

 

 

24,249

 

 

 

 

 

24,740

 

 

 

 

EBITDA

 

 

27,101

 

 

 

 

 

17,762

 

 

 

 

EBITDA reconciling items from below

 

 

281

 

 

 

 

 

20,780

 

 

 

 

Adjusted EBITDA

 

$

27,382

 

 

 

 

$

38,542

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciling Items

 

Three Months Ended
January 31, 2026

 

Three Months Ended
January 31, 2025

 

 

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Net sales

 

$

409,089

 

 

$

-

 

 

$

400,044

 

 

$

-

 

 

Cost of sales

 

 

310,562

 

 

 

(407

)

(1)

 

307,728

 

 

 

(9,007

)

(2)

Selling, general and administrative

 

 

71,426

 

 

 

126

 

(1),(3)

 

66,650

 

 

 

(3,869

)

(1),(3)

Restructuring charges

 

 

-

 

 

 

-

 

 

 

7,904

 

 

 

(7,904

)

(4)

EBITDA

 

 

27,101

 

 

 

281

 

 

 

17,762

 

 

 

20,780

 

 

Depreciation and amortization

 

 

24,249

 

 

 

(9,757

)

(5)

 

24,740

 

 

 

(10,650

)

(5)

Operating income (loss)

 

 

2,852

 

 

 

10,038

 

 

 

(6,978

)

 

 

31,430

 

 

Interest expense

 

 

(12,367

)

 

 

-

 

 

 

(14,186

)

 

 

-

 

 

Other, net

 

 

5,617

 

 

 

(5,072

)

(6)

 

1,229

 

 

 

(172

)

(6)

Loss before income taxes

 

 

(3,898

)

 

 

4,966

 

 

 

(19,935

)

 

 

31,258

 

 

Income tax benefit

 

 

(173

)

 

 

(1,165

)

(7)

 

5,050

 

 

 

(7,411

)

(7)

Net loss

 

$

(4,071

)

 

$

3,801

 

 

$

(14,885

)

 

$

23,847

 

 

 

 

 

 

 

 

 

 

 

 

Diluted loss per share

 

$

(0.09

)

 

 

 

$

(0.32

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Expense related to plant closure/relocation.

(2) Amortization of step-up for purchase price adjustments on inventory.

(3) Transaction, advisory fees, reorganization costs and product recall expenses.

(4) Restructuring charges related to severance and disposal of software.

(5) Amortization expense related to intangible assets.

(6) Foreign currency transaction gains.

(7) Tax impact of net income reconciling items.

 

 

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)

 

This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.

 

 

Hardware Solutions

 

Extruded Solutions

 

Custom Solutions

 

Unallocated Corp & Other

 

Total

Three months ended January 31, 2026

 

 

 

 

 

 

 

 

 

Net sales

$

189,112

 

 

$

139,800

 

 

$

89,142

 

 

$

(8,965

)

 

$

409,089

 

Cost of sales

 

150,724

 

 

 

97,709

 

 

 

71,424

 

 

 

(9,295

)

 

 

310,562

 

Gross Margin

 

38,388

 

 

 

42,091

 

 

 

17,718

 

 

 

330

 

 

 

98,527

 

Gross Margin %

 

20.3

%

 

 

30.1

%

 

 

19.9

%

 

 

 

 

24.1

%

Selling, general and administrative (1)

 

34,180

 

 

 

21,141

 

 

 

13,150

 

 

 

2,955

 

 

 

71,426

 

Depreciation and amortization

 

11,547

 

 

 

7,339

 

 

 

5,222

 

 

 

141

 

 

 

24,249

 

Operating (loss) income

 

(7,339

)

 

 

13,611

 

 

 

(654

)

 

 

(2,766

)

 

 

2,852

 

Depreciation and amortization

 

11,547

 

 

 

7,339

 

 

 

5,222

 

 

 

141

 

 

 

24,249

 

EBITDA

 

4,208

 

 

 

20,950

 

 

 

4,568

 

 

 

(2,625

)

 

 

27,101

 

Expense related to plant relocation (Cost of sales)

 

407

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

407

 

Credit related to plant relocation (SG&A)

 

(141

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(141

)

Transaction, advisory fees, reorganization costs, and product recall expenses

 

70

 

 

 

-

 

 

 

-

 

 

 

(55

)

 

 

15

 

Adjusted EBITDA

$

4,544

 

 

$

20,950

 

 

$

4,568

 

 

$

(2,680

)

 

$

27,382

 

Adjusted EBITDA Margin %

 

2.4

%

 

 

15.0

%

 

 

5.1

%

 

 

 

 

6.7

%

 

 

 

 

 

 

 

 

 

 

Three months ended January 31, 2025

 

 

 

 

 

 

 

 

 

Net sales

$

184,740

 

 

$

139,630

 

 

$

85,038

 

 

$

(9,364

)

 

$

400,044

 

Cost of sales

 

150,785

 

 

 

97,680

 

 

 

68,298

 

 

 

(9,035

)

 

 

307,728

 

Gross Margin

 

33,955

 

 

 

41,950

 

 

 

16,740

 

 

 

(329

)

 

 

92,316

 

Gross Margin %

 

18.4

%

 

 

30.0

%

 

 

19.7

%

 

 

 

 

23.1

%

Selling, general and administrative (1)

 

33,357

 

 

 

18,508

 

 

 

11,598

 

 

 

3,187

 

 

 

66,650

 

Restructuring charges

 

6,119

 

 

 

-

 

 

 

-

 

 

 

1,785

 

 

 

7,904

 

Depreciation and amortization

 

11,470

 

 

 

7,640

 

 

 

5,540

 

 

 

90

 

 

 

24,740

 

Operating (loss) income

 

(16,991

)

 

 

15,802

 

 

 

(398

)

 

 

(5,391

)

 

 

(6,978

)

Depreciation and amortization

 

11,470

 

 

 

7,640

 

 

 

5,540

 

 

 

90

 

 

 

24,740

 

EBITDA

 

(5,521

)

 

 

23,442

 

 

 

5,142

 

 

 

(5,301

)

 

 

17,762

 

Transaction, advisory fees, reorganization costs, and product recall expenses

 

90

 

 

 

158

 

 

 

-

 

 

 

3,621

 

 

 

3,869

 

Amortization of step-up for purchase price adjustments on inventory

 

7,509

 

 

 

352

 

 

 

1,146

 

 

 

-

 

 

 

9,007

 

Restructuring charges

 

6,119

 

 

 

-

 

 

 

-

 

 

 

1,785

 

 

 

7,904

 

Adjusted EBITDA

$

8,197

 

 

$

23,952

 

 

$

6,288

 

 

$

105

 

 

$

38,542

 

Adjusted EBITDA Margin %

 

4.4

%

 

 

17.2

%

 

 

7.4

%

 

 

 

 

9.6

%

 

 

 

 

 

 

 

 

 

 

(1) Includes stock-based compensation expense of $3.0 million and $1.2 million for the three months ended January 31, 2026 and January 31, 2025, respectively.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA RECONCILIATION
(In thousands)
(Unaudited)

 

This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated March 10, 2025 for the three months ended January 31, 2025, to the current presentation.

 

 

 

NA Fenestration

 

EU Fenestration

 

NA Cabinet Components

 

Tyman

 

Unallocated Corp & Other

 

Total

Three months ended January 31, 2025

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

134,333

 

 

$

48,471

 

 

$

43,810

 

 

$

175,676

 

 

$

(2,246

)

 

$

400,044

 

Cost of sales

 

 

106,567

 

 

 

30,638

 

 

 

39,415

 

 

 

132,796

 

 

 

(1,688

)

 

 

307,728

 

Gross Margin

 

 

27,766

 

 

 

17,833

 

 

 

4,395

 

 

 

42,880

 

 

 

(558

)

 

 

92,316

 

Gross Margin %

 

 

20.7

%

 

 

36.8

%

 

 

10.0

%

 

 

24.4

%

 

 

 

 

23.1

%

Selling, general and administrative

 

 

16,133

 

 

 

7,920

 

 

 

5,268

 

 

 

34,378

 

 

 

2,951

 

 

 

66,650

 

Restructuring charges

 

 

-

 

 

 

-

 

 

 

-

 

 

 

7,904

 

 

 

-

 

 

 

7,904

 

Depreciation and amortization

 

 

4,779

 

 

 

2,610

 

 

 

3,009

 

 

 

14,263

 

 

 

79

 

 

 

24,740

 

Operating income (loss)

 

 

6,854

 

 

 

7,303

 

 

 

(3,882

)

 

 

(13,665

)

 

 

(3,588

)

 

 

(6,978

)

Depreciation and amortization

 

 

4,779

 

 

 

2,610

 

 

 

3,009

 

 

 

14,263

 

 

 

79

 

 

 

24,740

 

EBITDA

 

 

11,633

 

 

 

9,913

 

 

 

(873

)

 

 

598

 

 

 

(3,509

)

 

 

17,762

 

Amortization of step-up for purchase price adjustments on inventory

 

 

-

 

 

 

-

 

 

 

-

 

 

 

9,007

 

 

 

-

 

 

 

9,007

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,469

 

 

 

2,400

 

 

 

3,869

 

Restructuring charges

 

 

 

 

 

 

 

 

7,904

 

 

 

-

 

 

 

7,904

 

Adjusted EBITDA

 

$

11,633

 

 

$

9,913

 

 

$

(873

)

 

$

18,978

 

 

$

(1,109

)

 

$

38,542

 

Adjusted EBITDA Margin %

 

 

8.7

%

 

 

20.5

%

 

 

-2.0

%

 

 

10.8

%

 

 

 

 

9.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hardware Solutions(1)

 

Extruded Solutions(2)

 

Custom Solutions(3)

 

Tyman

 

Unallocated Corp & Other

 

Total

Three months ended January 31, 2025

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

184,740

 

 

$

139,630

 

 

$

85,038

 

 

$

-

 

 

$

(9,364

)

 

$

400,044

 

Cost of sales

 

 

150,785

 

 

 

97,680

 

 

 

68,298

 

 

 

-

 

 

 

(9,035

)

 

 

307,728

 

Gross Margin

 

 

33,955

 

 

 

41,950

 

 

 

16,740

 

 

 

-

 

 

 

(329

)

 

 

92,316

 

Gross Margin %

 

 

18.4

%

 

 

30.0

%

 

 

19.7

%

 

 

 

 

 

 

23.1

%

Selling, general and administrative

 

 

33,357

 

 

 

18,508

 

 

 

11,598

 

 

 

 

 

3,187

 

 

 

66,650

 

Restructuring charges

 

 

6,119

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,785

 

 

 

7,904

 

Depreciation and amortization

 

 

11,470

 

 

 

7,640

 

 

 

5,540

 

 

 

-

 

 

 

90

 

 

 

24,740

 

Operating (loss) income

 

 

(16,991

)

 

 

15,802

 

 

 

(398

)

 

 

-

 

 

 

(5,391

)

 

 

(6,978

)

Depreciation and amortization

 

 

11,470

 

 

 

7,640

 

 

 

5,540

 

 

 

-

 

 

 

90

 

 

 

24,740

 

EBITDA

 

 

(5,521

)

 

 

23,442

 

 

 

5,142

 

 

 

-

 

 

 

(5,301

)

 

 

17,762

 

Reorganization costs (SG&A)

 

 

 

 

 

 

 

 

 

 

2,400

 

 

 

2,400

 

Amortization of step-up for purchase price adjustments on inventory

 

 

7,509

 

 

 

352

 

 

 

1,146

 

 

 

-

 

 

 

-

 

 

 

9,007

 

Transaction and advisory fees

 

 

90

 

 

 

158

 

 

 

-

 

 

 

-

 

 

 

1,221

 

 

 

1,469

 

Restructuring charges

 

 

6,119

 

 

 

 

 

 

 

 

 

1,785

 

 

 

7,904

 

Adjusted EBITDA

 

$

8,197

 

 

$

23,952

 

 

$

6,288

 

 

$

-

 

 

$

105

 

 

$

38,542

 

Adjusted EBITDA Margin %

 

 

4.4

%

 

 

17.2

%

 

 

7.4

%

 

 

 

 

 

 

9.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Contains a portion of the previously reported NA Fenestration segment.

(2) Contains a portion of the NA Fenestration segment and the EU Fenestration segment.

(3) Contains a portion of the NA Fenestration segment and the NA Cabinet Components segment.

 

 

 

 

 

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)

 

 

 

Three Months Ended January 31,

 

 

2026

 

2025

 

 

 

 

 

Hardware Solutions:(1)

 

 

 

 

Window and door hardware

$

124,701

 

 

$

122,353

 

 

Screens

 

62,599

 

 

 

60,554

 

 

Other

 

1,812

 

 

 

1,833

 

 

 

$

189,112

 

 

$

184,740

 

Extruded Solutions:(2)

 

 

 

 

Window profiles

$

58,355

 

 

$

59,845

 

 

Seals and gaskets

 

17,634

 

 

 

18,041

 

 

Spacers

 

47,602

 

 

 

42,861

 

 

Solar

 

4,605

 

 

 

5,523

 

 

Flashing Tape

 

1,518

 

 

 

2,114

 

 

Window and door hardware

 

7,512

 

 

 

9,458

 

 

Other

 

2,574

 

 

 

1,788

 

 

 

$

139,800

 

 

$

139,630

 

Custom Solutions:(3)

 

 

 

 

Wood solutions

$

46,654

 

 

$

43,810

 

 

Access solutions

 

23,045

 

 

 

22,908

 

 

Mixing solutions

 

19,443

 

 

 

18,320

 

 

 

$

89,142

 

 

$

85,038

 

 

 

 

 

 

Unallocated Corporate & Other:

 

 

 

 

Eliminations

$

(8,965

)

 

$

(9,364

)

 

 

$

(8,965

)

 

$

(9,364

)

 

 

 

 

 

Net Sales

$

409,089

 

 

$

400,044

 

 

 

 

 

 

(1) Reflects an increase of $4.3 million in revenue associated with foreign currency exchange rate impacts for the three months ended January 31, 2026.

(2) Reflects an increase of $3.3 million in revenue associated with foreign currency exchange rate impacts for the three months ended January 31, 2026.

(3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three months ended January 31, 2026.